Abstract
Perinuclear anti-neutrophil cytoplasmicantibodies (P-ANCA) of the IgG class have been reportedin inflammatory bowel disease, mainly in ulcerativecolitis. Since this disease affects the gastrointestinal tract, we determined whether IgA class ANCAwere present in inflammatory bowel disease. We used anindirect immunofluorescence assay for IgG and IgA ANCAtesting. Sera from 34 patients with Crohn's disease and 29 patients with ulcerative colitis werecollected together with clinical and laboratory data. Wefound IgA class ANCA of a perinuclear type in 52% ofpatients with ulcerative colitis and in 9% of Crohn's disease patients. There was a significantassociation between the presence of IgA ANCA and theoccurrence of blood in the feces in the ulcerativecolitis group (P = 0.03). IgG ANCA was found in 56% ofpatients with ulcerative colitis and in 7% of patientswith Crohn's disease. Because of partial overlap betweenIgG and IgA ANCA positivity, the sensitivity of ANCAtesting in ulcerative colitis increased from 56% up to 78% by combining IgG and IgA assays. Inconclusion, IgA ANCA occurs with a high prevalence inulcerative colitis. Moreover there is a possiblerelationship between IgA ANCA and disease activity in ulcerative colitis.
Similar content being viewed by others
REFERENCES
van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1:425-429, 1985
Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of anti-neutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202-210, 1990
Falk RJ, Sartor RB, Jones DA, Jeffries BD, Jennette JC: Antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis (abstr). Clin Res 38:387A, 1990
Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Neutrophila autoantibodies in ulcerative colitis. Camparison with other colitides/diarrheal disease. Gastroenterology 100:1590-1596, 1991
Rump JA, Schölmerich J, Gross V: A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 181:406-413, 1990
Mulder AH, Broekroelofs J, Horst G, Limurg PC, Nelis GF, Kallenberg CG: Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: Characterization and clinical correlates. Clin Exp Immunol 95:490-497, 1994
Stoffel MP, Csernok E, Herzberg C, Johnson T, Carroll SF, Gross WL: Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): A new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 104:54-59, 1996
Shanahan F: Neutrophil autoantibodies in inflammatory bowel disease: Are they important? Gastroenterology 107:586-589, 1994
Cambridge, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B: Anti-neutrophil antibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 33:668-674, 1992
Oudkerk Pool M, Ellerbroek PM, Ridwan BU: Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut 34:46-50, 1993
Rump JA, Worner I, Roth M, Scholmerich J, Hansch M, Peter HH: p-ANCA of undefined specificity in ulcerative colitis: Correlation to disease activity and therapy. Adv Exp Med Biol 336:507-513, 1993
Levinsky RJ, Barratt TM: IgA immune complexes in Henoch-Schönlein purpura. Lancet 2:1100-1103, 1979
Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH: Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 33:657-662, 1992
Targan SR, Landers CJ, Cobb L, MacDermott RP, Vidrich A: Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J Immunol 155:3262-3267, 1995
Mestecky J, McGhee JR, Elson CO: Intestinal IgA system. Immunol Allergy Clin North Am 8:349-368, 1988
Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115-4119, 1990
Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JWW, Weening JJ, Kallenberg CG: Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 45:1120-1131, 1994
Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP: Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153:1271-1280, 1994
Broekroelofs J, Mulder AH, Nelis GF, Westerveld BD, Tervaert JW, Kallenberg CG: Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig Dis Sci 39:545-549, 1994
Van der Wall-Bake, AWL, Lobatto S, Joges L: IgA antibodies against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schönlein purpura. Adv Exp Med Biol 16:1593-1598, 1987
Rights and permissions
About this article
Cite this article
Gigase, P., Clerck, L.S.D., Cotthem, K.A.V. et al. Anti-Neutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease with Special Attention for IgA-Class Antibodies. Dig Dis Sci 42, 2171–2174 (1997). https://doi.org/10.1023/A:1018803509150
Issue Date:
DOI: https://doi.org/10.1023/A:1018803509150